相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
T. A. Seldon et al.
LEUKEMIA (2016)
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala et al.
HAEMATOLOGICA (2015)
The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo
Julianna Blagih et al.
IMMUNITY (2015)
CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response
Brian C. Betts et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity
Martin Vaeth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Low expression of CD39 on regulatory T cells as a biomarker for resistance to methotrexate therapy in rheumatoid arthritis
Raphael Sanches Peres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention
Scott N. Furlan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease
Joseph Pidala et al.
HAEMATOLOGICA (2015)
A Cell Biologist's Field Guide to Aurora Kinase Inhibitors
Christian O. de Groot et al.
FRONTIERS IN ONCOLOGY (2015)
Superiority of Rapamycin Over Tacrolimus in Preserving Nonhuman Primate Treg Half-Life and Phenotype After Adoptive Transfer
K. Singh et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Corey Cutler et al.
BLOOD (2014)
Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
Christopher G. Kanakry et al.
BLOOD (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
STAT5 polarization promotes iTregs and suppresses human T-cell alloresponses while preserving CTL capacity
Brian C. Betts et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial
Glen A. Kennedy et al.
LANCET ONCOLOGY (2014)
Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect
Jaebok Choi et al.
PLOS ONE (2014)
Dual Aurora A and JAK2 kinase blockade effectively suppresses malignant transformation
Hua Yang et al.
ONCOTARGET (2014)
Interleukin-6 Receptor Blockade Enhances CD39+Regulatory T Cell Development in Rheumatoid Arthritis and in Experimental Arthritis
A. Thiolat et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo
Annkristin Heine et al.
BLOOD (2013)
Ruxolitinib is a potent immunosuppressive compound: is it time for anti-infective prophylaxis?
Annkristin Heine et al.
BLOOD (2013)
Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantation
L. Johnston et al.
BONE MARROW TRANSPLANTATION (2012)
Depletion of T regulatory cells through selection of CD127-positive cells results in a population enriched in memory T cells: implications for anti-tumor cell therapy
Soumia Touil et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
STAT3 Transcription Factor Promotes Instability of nTreg Cells and Limits Generation of iTreg Cells during Acute Murine Graft-versus-Host Disease
Arian Laurence et al.
IMMUNITY (2012)
Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation
Marcelo C. Pasquini et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
IL-7 Abrogates Suppressive Activity of Human CD4+CD25+ FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
Anne-Kristin Heninger et al.
JOURNAL OF IMMUNOLOGY (2012)
Development of o-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors
Harshani R. Lawrence et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses
Brian C. Betts et al.
BLOOD (2011)
Janus kinase-2 inhibition induces durable tolerance to alloantigen by human dendritic cell-stimulated T cells yet preserves immunity to recall antigen
Brian C. Betts et al.
BLOOD (2011)
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays
Mark G. Manfredi et al.
CLINICAL CANCER RESEARCH (2011)
Functional characterization of alloreactive T cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy
Sujith Samarasinghe et al.
BLOOD (2010)
Generation and Accumulation of Immunosuppressive Adenosine by Human CD4+CD25highFOXP3+ Regulatory T Cells
Magis Mandapathil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Shared and separate functions of polo-like kinases and aurora kinases in cancer
Susanne M. A. Lens et al.
NATURE REVIEWS CANCER (2010)
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
John Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
Gerlinde Werning et al.
CANCER CELL (2008)
Differential impact of mammalian target of rapamycin inhibition on CD4(+)CD25(+)Foxp3(+) regulatory T cells compared with conventional CD4(+) T cells
Robert Zeiser et al.
BLOOD (2008)
The kinases aurora B and mTOR regulate the G1-S cell cycle progression of T lymphocytes
Jianxun Song et al.
NATURE IMMUNOLOGY (2007)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Nabila Seddiki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production
Robert Zeiser et al.
BLOOD (2006)
Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
Ting-Chao Chou
PHARMACOLOGICAL REVIEWS (2006)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Calcein-acetyoxymethyl cytotoxicity assay: Standardization of a method allowing additional analyses on recovered effector cells and supernatants
S Neri et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2001)
CD28-Specific antibody prevents graft-versus-host disease in mice
XZ Yu et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
